100 filings
Page 3 of 5
8-K
k1u1nhxc3
8 Feb 22
Departure of Directors or Certain Officers
4:23pm
8-K
eynhn8m2biuxn3e0if
4 Jan 22
Other Events
8:08am
8-K
j20q9cff
3 Jan 22
Genprex Receives U.S. FDA Fast Track Designation for REQORSA™ Immunogene Therapy
8:08am
8-K
688 ta3vj1p
17 Nov 21
Other Events
7:30am
8-K
l7xlowx
15 Oct 21
Departure of Directors or Certain Officers
4:36pm
8-K
8emu7i1p vf1e79
29 Sep 21
Departure of Directors or Certain Officers
4:17pm
8-K
kkhqz2tl78a7qru6x6
28 Sep 21
Departure of Directors or Certain Officers
4:17pm
8-K
rcuzcjcu9d2za
12 Jul 21
Other Events
8:14am
8-K
2gg x7pwux
28 Jun 21
Genprex Announces Initiation of its Phase 1/2 Acclaim-1 Clinical Trial for REQORSA™ Immunogene Therapy
4:22pm
8-K
ty9z1gwzas8
13 May 21
Other Events
4:58pm
8-K
2d66vbe
25 Mar 21
Departure of Directors or Certain Officers
4:24pm
8-K
1im5l agpkn
9 Mar 21
Entry into a Material Definitive Agreement
9:06am
8-K
dbxhzsc9f vpcm3n
2 Mar 21
Other Events
4:44pm
8-K
wpzgpvr2vj42wqds30s
9 Feb 21
Genprex, Inc. Announces $25 Million
4:59pm
8-K
ollklt
28 Jan 21
Other Events
4:30pm
8-K
4si3lsh4xkex
23 Dec 20
Genprex, Inc. Announces $12 Million
4:41pm
8-K
4wi5 ihwup
16 Nov 20
Other Events
4:33pm
8-K
1pnt2avi5
29 Sep 20
Other Events
9:06am
8-K
db8lq2juap ib
27 Aug 20
Departure of Directors or Certain Officers
4:21pm
8-K
56kugktca
14 Aug 20
Departure of Directors or Certain Officers
8:39am